RxDoctor Payments Data

Ashley Mulder, MD

Family Medicine · Lake Havasu City, AZNPI 1104455989

Payments from drug & device makers

$823in general payments, 2019–2025

Across 35 payments — averaging $23.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astellas Pharma US Inc$125
  • Amgen$117
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$107
  • Lilly USA, LLC$91
  • Corcept Therapeutics$85
  • Exact Sciences$83
  • plus $215 from 8 others

What the payments were for

  • Food & beverage$823100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$823 in reported general payments places this provider in the 65th percentile of 2,099 family medicine providers in Arizona.

See all family medicine providers in Arizona

Medicare billing

Part B allowed, 2024
$195,930
Medicare patients
422
Services billed
2,207

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide62$77,035
EliquisApixaban42$52,790
MounjaroTirzepatide30$30,978
Repatha SureclickEvolocumab22$24,032
FarxigaDapagliflozin Propanediol16$20,611
JardianceEmpagliflozin14$15,066
GemtesaVibegron13$11,356
Tolterodine Tartrate ErTolterodine Tartrate41$4,669
Estradiol74$4,382
Levothyroxine Sodium359$3,474
Albuterol Sulfate HfaAlbuterol Sulfate63$2,590
SynthroidLevothyroxine Sodium29$2,275
Duloxetine Hcl57$2,083
Rosuvastatin Calcium221$2,032
Lantus SolostarInsulin Glargine,hum.Rec.Anlog14$1,811

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$46$52,79042 claims
Lilly USA, LLCMounjaro$91$30,97830 claims
AstraZenecaFarxiga$24$20,61116 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 2,099 family medicine providers in Arizona.

Other family medicine in Lake Havasu City

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →